TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Tue Sep 16

NL

Article

EBCapitalMarkets published an article 7:49 PM

3 Best Stocks for Investing in Biotech

Gilead Sciences, Celgene Corp, and BioMarin are three biotech industry companies that are revolutionizing how doctors treat patients.

NL

Article

EBCapitalMarkets published an article 3:52 PM

Rite Aid Corporation Stock Earnings: 3 Key Things to Watch

Here are three important questions Rite Aid needs to address during its earnings conference call on September 18th.

NL

Article

EBCapitalMarkets published an article 12:25 PM

Why CVS Health Corporation Is Up 14.8% in 2014

CVS Health's shift toward primary care services is boosting both sales and share prices.

NL

Article

EBCapitalMarkets published an article 10:07 AM

Why Amgen Inc.'s Stock Is up 23% in 2014

Amgen is rallying on hope surrounding a new class of PCSK9 inhibitors designed to reduce bad cholesterol.

Mon Sep 15

NL

Article

EBCapitalMarkets published an article 9:49 AM

Why Is Gilead Sciences, Inc. Stock Offering This Drug for Cheap?

Gilead Sciences will collect royalties on generic Sovaldi beginning as early as next year, even as it launches its next generation hepatitis C drug here in the United States.

Sat Sep 13

NL

Article

EBCapitalMarkets published an article 11:11 PM

Gilead Sciences, inc. Stock's Incoming Game Changer

Gilead's Sovaldi sales could reach $10 billion this year, but sales could head even higher next year if the FDA approves its Sovaldi and ledipasvir combination drug.

Thu Sep 11

NL

Article

EBCapitalMarkets published an article 4:21 PM

Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr

A new weight loss pill from Orexigen will face stiff competition from Arena's Belviq and may soon have to compete against Novo Nordisk's Saxenda.

NL

Article

EBCapitalMarkets published an article 12:51 PM

Why ISIS Pharmaceuticals Inc. Stock Is Flat in 2014

ISIS Pharmaceuticals shares have rebounded since spring, but still remain unchanged this year as investors digest a big stock move last year and wait for further proof that antisense RNA technology has blockbuster potential.

NL

Article

EBCapitalMarkets published an article 10:15 AM

Why Biogen Idec Inc's Stock is Up 17% in 2014

Biogen's Tecfidera, an oral multiple sclerosis treatment, is helping lift its stock this year, but Tecfidera isn't the only reason Biogen's shares may continue to climb.

Wed Sep 10

NL

Article

EBCapitalMarkets published an article 5:07 PM

Is It Time to Buy Express Scripts Stock?

Express Scripts could see demand growth thanks to the launch of high-priced medicine, but that may not mean that now is the right time to buy.

NL

Article

EBCapitalMarkets published an article 11:50 AM

Why Cloud Hackers Could Come for Your Health Data Next

Hackers are exploiting the heartbleed bug as part of their increased attacks to steal private healthcare information.

NL

Article

EBCapitalMarkets published an article 10:18 AM

Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment?

Despite worries over reefer madness, research by GW Pharmaceuticals might show that medical marijuana may reduce schizophrenia symptoms.

Tue Sep 9

NL

Article

EBCapitalMarkets published an article 4:06 PM

Apple Watch's Huge Future Opportunity

Apple Watch aims to provide consumers with a brand new way of tracking and monitoring health.

NL

Article

EBCapitalMarkets published an article 2:15 PM

Why Celgene's Stock is up 11% in 2014

Celgene has gained ground this year thanks to steady growth of Revlimid, Abraxane, and Pomalyst, but it may be Otezla that could push shares up into the end of the year.

NL

Article

EBCapitalMarkets published an article 12:46 PM

How Bad Is This News for Celgene Corporation?

The National Institute for Health and Care Excellence has balked at paying for Celgene's Abraxane, but that decision may not last.

Mon Sep 8

NL

Article

EBCapitalMarkets published an article 7:41 PM

Why Gilead Sciences Stock Is Up 40% in 2014

Gilead's shares have surged this year, but that may not mean the shares are ready to drop.

NL

Article

EBCapitalMarkets published an article 10:12 AM

Teva Pharmaceuticals New Drug Aims to Reduce Asthma Attacks

Teva Pharmaceutical's reslizumab may some day offer a new treatment option for moderate and severe asthma patients.

Fri Sep 5

NL

Article

EBCapitalMarkets published an article 5:49 PM

General Electric Company Notches an Important Win Against Breast Cancer

General Electric Company has won FDA approval for its new 3-D mammography machine that should improve early detection of invasive breast cancer.

NL

Article

EBCapitalMarkets published an article 12:08 PM

Hackers Fire Warning Shot at Healthcare.gov

The Department of Health and Human Services reports that hackers breached a server used on its healthcare.gov marketplace, but that doesn't mean your data was stolen.

NL

Article

EBCapitalMarkets published an article 9:58 AM

Is a Cheap Hepatitis C Cure About to Go Global?

Gilead Sciences is negotiating with generic drugmakers in a bid to bring Sovaldi to needy nations with large hepatitis C patient populations.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 23.11
Player Rank 57699 out of 75038
Score -197.76
Score Change Today +8.48
Accuracy 35.29%
Active Picks 34
Total Picks 34
Best Pick GILD (+62.89)
Worst Pick WFM (-48.04)
Average Score per Pick -5.82
Charms Earned 5
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts